Substrates for peptidase M04.005: pseudolysin
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abz-Ala-Gly-Leu-Ala-Nba | Abz-Ala-Gly+Leu-Ala-Nba | S | - | Abz | Ala | Gly | Leu | Ala | Nba | - | Kessler & Ohman, 2004 | |||||
| alpha-1-antichymotrypsin | P01011 | 24-423 | peptide-Ala362+Leu-peptide | N | Leu | Leu | Ser | Ala | Leu | Val | Glu | Thr | 16454 | |||
| alpha-1-peptidase inhibitor | P01009 | 25-418 | peptide-Pro357+Met-peptide | N | Glu | Ala | Ile | Pro | Met | Ser | Ile | Pro | Morihara et al., 1984 | 19105 | ||
| Antitrypsin | P22922 | 17-392 | Peptide-Ala351+Phe-Peptide | P | NT | Ala | Ala | Asn | Ala | Phe | Thr | Met | Thr | Sasaki et al., 1990 | ||
| Antitrypsin | P22922 | 17-392 | Peptide-Tyr361+Val-Peptide | P | NT | Ser | Lys | Val | Tyr | Val | Arg | Pro | Pro | Sasaki et al., 1990 | ||
| cathelicidin antimicrobial peptide | P49913 | 132-170 | peptide-Lys145+Ile-peptide | N | Ser | Lys | Glu | Lys | Ile | Gly | Lys | Glu | Schmidtchen et al.,2002 | |||
| cathelicidin antimicrobial peptide | P49913 | 132-170 | peptide-Glu149+Phe-peptide | N | Ile | Gly | Lys | Glu | Phe | Lys | Arg | Ile | Schmidtchen et al.,2002 | |||
| cathelicidin antimicrobial peptide | P49913 | 132-170 | peptide-Arg152+Ile-peptide | N | Glu | Phe | Lys | Arg | Ile | Val | Gln | Arg | Schmidtchen et al.,2002 | |||
| cathelicidin antimicrobial peptide | P49913 | 132-170 | peptide-Arg156+Ile-peptide | N | Ile | Val | Gln | Arg | Ile | Lys | Asp | Phe | Schmidtchen et al.,2002 | |||
| cathelicidin antimicrobial peptide | P49913 | 132-170 | peptide-Asp159+Phe-peptide | N | Arg | Ile | Lys | Asp | Phe | Leu | Arg | Asn | Schmidtchen et al.,2002 | |||
| cathelicidin antimicrobial peptide | P49913 | 132-170 | peptide-Asn163+Leu-peptide | N | Phe | Leu | Arg | Asn | Leu | Val | Pro | Arg | Schmidtchen et al.,2002 | |||
| Dabcyl-Ser-Phe-EDANS | Dabcyl-Ser+Phe-EDANS | S | - | - | Dab | Ser | Phe | Ens | - | - | Weimer et al., 2006 | |||||
| elafin | P19957 | 61-117 | peptide-Met85+Leu-peptide | N | Arg | Cys | Ala | Met | Leu | Asn | Pro | Pro | Guyot et al., 2010 | |||
| FA-Gly-Leu-NH2 | FA-Gly+Leu-NH2 | S | - | - | FA | Gly | Leu | NH2 | - | - | Morihara, 1995 | |||||
| furylacryloyl-Gly-Leu-Ala-NH2 | furylacryloyl-Gly+Leu-Ala-NH2 | S | - | - | FA | Gly | Leu | Ala | NH2 | - | Kessler & Ohman, 2004 | |||||
| furylacryloyl-Gly-Leu-NH2 | furylacryloyl-Gly+Leu-NH2 | S | - | - | FA | Gly | Leu | NH2 | - | - | Kessler & Ohman, 2004 | |||||
| H-Phe-Gly-Gly-Leu-Ala | H-Phe-Gly-Gly+Leu-Ala | S | - | Phe | Gly | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| H-Phe-Gly-Leu-Ala | H-Phe-Gly+Leu-Ala | S | - | - | Phe | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His+Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Val | Asn | Gln | His | Leu | Cya | Gly | Ser | Dumont et al., 1994 | 24067 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His+Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Cya | Gly | Ser | His | Leu | Val | Glu | Ala | Dumont et al., 1994 | 24068 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala+Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Leu | Val | Glu | Ala | Leu | Tyr | Leu | Val | Dumont et al., 1994 | 24069 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr+Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Glu | Ala | Leu | Tyr | Leu | Val | Cya | Gly | Dumont et al., 1994 | 24070 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu+Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Ala | Leu | Tyr | Leu | Val | Cya | Gly | Glu | Dumont et al., 1994 | 24071 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly+Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Gly | Glu | Arg | Gly | Phe | Phe | Tyr | Thr | Dumont et al., 1994 | 24072 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe+Phe-Tyr-Thr-Pro-Lys-Ala | N | Glu | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Dumont et al., 1994 | 24073 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe+Tyr-Thr-Pro-Lys-Ala | N | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Lys | Dumont et al., 1994 | 24074 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys+Ala | N | Tyr | Thr | Pro | Lys | Ala | - | - | - | Dumont et al., 1994 | 24075 | ||
| matrix metallopeptidase-1 precursor | P03956 | 20-469 | peptide-Val101+Leu-peptide | N | Ala | Gln | Phe | Val | Leu | Thr | Glu | Gly | Okamoto et al., 1997 | 19812 | ||
| matrix metallopeptidase-1 precursor | P03956 | peptide-Pro269+-peptide | N | Pro | Val | Gln | Pro | - | - | - | - | Okamoto et al., 1997 | ||||
| matrix metallopeptidase-9 | P14780 | peptide-Thr109+Phe-peptide | N | Arg | Phe | Gln | Thr | Phe | Glu | Gly | Asp | Okamoto et al., 1997 | 19816 | |||
| probable aminopeptidase | Q9HZQ8 | 25-536 | peptide-Ser517+Leu-peptide | P | NT | Gln | Ser | Arg | Ser | Leu | Gln | Met | Gln | Sarnovsky et al., 2009 | ||
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Ser37+Leu-peptide | N | Lys | Gly | Arg | Ser | Leu | Ile | Gly | Lys | Leduc et al., 2005 | 26228 | ||
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Gly52+Val-peptide | N | Thr | Gly | Lys | Gly | Val | Thr | Val | Glu | Leduc et al., 2005 | 26229 | ||
| proteinase-activated receptor 2 | Q63645 | 26-397 | peptide-Ser37+Leu-peptide | P | Lys | Gly | Arg | Ser | Leu | Ile | Gly | Arg | Leduc et al., 2005 | 26230 | ||
| pseudolysin | P14756 | 24-498 | peptide-His197+Ala-peptide | P | NT | Gly | Leu | Ala | His | Ala | Glu | Ala | Gly | McIver et al., 1991 | ||
| pulmonary surfactant-associated protein D | P35248 | 20-374 | peptide-Gly111+Ile-peptide | P | Gly | Ser | Pro | Gly | Ile | Ser | Gly | Pro | Alcorn & Wright, 2004 | 19755 | ||
| pulmonary surfactant-associated protein D | P35248 | 20-374 | peptide-Ser258+Val-peptide | P | Asp | Gly | Gln | Ser | Val | Gly | Asp | Lys | Alcorn & Wright, 2004 | 19756 | ||
| pulmonary surfactant-associated protein D | P35248 | 20-374 | peptide-Ala266+Ala-peptide | P | Ile | Phe | Arg | Ala | Ala | Asn | Ser | Glu | Alcorn & Wright, 2004 | 19757 | ||
| pulmonary surfactant-associated protein D | P35248 | 20-374 | peptide-Lys322+Phe-peptide | P | Thr | Glu | Gly | Lys | Phe | Thr | Tyr | Pro | Alcorn & Wright, 2004 | 19758 | ||
| pulmonary surfactant-associated protein D | P35248 | 20-374 | peptide-Asn335+Trp-peptide | P | Val | Tyr | Ser | Asn | Trp | Ala | Pro | Gly | Alcorn & Wright, 2004 | 19759 | ||
| Suc-Ala-Ala-Ala-NHPhNO2 | Suc-Ala+Ala-Ala-NHPhNO2 | S | - | - | Suc | Ala | Ala | Ala | NAN | - | Kessler & Ohman, 2004 | |||||
| Suc-Ala-Ala-Pro-Phe-NHPhNO2 | Suc-Ala-Ala-Pro+Phe-NHPhNO2 | S | Suc | Ala | Ala | Pro | Phe | NAN | - | - | Kessler & Ohman, 2004 | |||||
| urokinase plasminogen activator surface receptor | Q03405 | 23-305 | peptide-Ala106+Val-peptide | N | Ser | Gly | Arg | Ala | Val | Thr | Tyr | Ser | Leduc et al., 2007 | 24111 | ||
| urokinase plasminogen activator surface receptor | Q03405 | 23-305 | peptide-Thr108+Tyr-peptide | N | Arg | Ala | Val | Thr | Tyr | Ser | Arg | Ser | Leduc et al., 2007 | 24110 | ||
| urokinase plasminogen activator surface receptor | Q03405 | 23-305 | peptide-Gln301+Tyr-peptide | N | Leu | Asp | Val | Gln | Tyr | Arg | Ser | Gly | Leduc et al., 2007 | 24112 | ||
| urokinase-type plasminogen activator | P00749 | 21-431 | peptide-Lys178+Ile-peptide | N | Pro | Arg | Phe | Lys | Ile | Ile | Gly | Gly | Beaufort et al.,2010 | |||
| Z-Ala-Ala-Phe-Ala-NH2 | Z-Ala-Ala+Phe-Ala-NH2 | S | - | Z | Ala | Ala | Phe | Ala | NH2 | - | Kessler & Ohman, 2004 | |||||
| Z-Ala-Gly-Gly-Leu-Ala | Z-Ala-Gly-Gly+Leu-Ala | S | Z | Ala | Gly | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Ala-Gly-Leu-Ala | Z-Ala-Gly+Leu-Ala | S | - | Z | Ala | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Ala-Leu-Ala | Z-Ala+Leu-Ala | S | - | - | Z | Ala | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-D-Ala-Gly-Gly-Leu-Ala | Z-D-Ala-Gly-Gly+Leu-Ala | S | Z | DAl | Gly | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-D-Ala-Gly-Leu-Ala | Z-D-Ala-Gly+Leu-Ala | S | - | Z | DAl | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Gly-Leu-Ala | Z-Gly-Gly+Leu-Ala | S | - | Z | Gly | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Ala | Z-Gly+Leu-Ala | S | - | - | Z | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Gly | Z-Gly+Leu-Gly | S | - | - | Z | Gly | Leu | Gly | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Gly-Ala | Z-Gly+Leu-Gly-Ala | S | - | - | Z | Gly | Leu | Gly | Ala | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Gly-Gly | Z-Gly+Leu-Gly-Gly | S | - | - | Z | Gly | Leu | Gly | Gly | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Gly-Gly-Ala | Z-Gly+Leu-Gly-Gly-Ala | S | - | - | Z | Gly | Leu | Gly | Gly | Ala | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Gly-Gly-D-Ala | Z-Gly+Leu-Gly-Gly-D-Ala | S | - | - | Z | Gly | Leu | Gly | Gly | DAl | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Gly-Phe | Z-Gly+Leu-Gly-Phe | S | - | - | Z | Gly | Leu | Gly | Phe | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Leu | Z-Gly+Leu-Leu | S | - | - | Z | Gly | Leu | Leu | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Leu-Phe | Z-Gly+Leu-Phe | S | - | - | Z | Gly | Leu | Phe | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Gly-Phe-NH2 | Z-Gly+Phe-NH2 | S | - | - | Z | Gly | Phe | NH2 | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Phe-Gly-Gly-Leu-Ala | Z-Phe-Gly-Gly+Leu-Ala | S | Z | Phe | Gly | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Phe-Gly-Leu-Ala | Z-Phe-Gly+Leu-Ala | S | - | Z | Phe | Gly | Leu | Ala | - | - | Morihara & Tsuzuki, 1971 | |||||
| Z-Phe-Ile-Ala | Z-Phe+Ile-Ala | S | - | - | Z | Phe | Ile | Ala | - | - | Kessler & Ohman, 2004 | |||||
| Z-Phe-Leu-Ala | Z-Phe+Leu-Ala | S | - | - | Z | Phe | Leu | Ala | - | - | Kessler & Ohman, 2004 | |||||
| Z-Phe-Phe-Ala | Z-Phe+Phe-Ala | S | - | - | Z | Phe | Phe | Ala | - | - | Kessler & Ohman, 2004 | |||||
| Z-Phe-Tyr-Ala | Z-Phe+Tyr-Ala | S | - | - | Z | Phe | Tyr | Ala | - | - | Kessler & Ohman, 2004 | |||||
| Z-Phe-Val-Ala | Z-Phe+Val-Ala | S | - | - | Z | Phe | Val | Ala | - | - | Kessler & Ohman, 2004 |
